Jyoti Iravane

Aurangabad, MH, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

From lines to lifelines: a quality improvement study to reduce CLABSI at a level III NICU in LMIC.

From lines to lifelines: a quality improvement study to reduce CLABSI at a level III NICU in LMIC.

Journal: BMJ open quality

Published: September 26, 2025

Epidemiology of non-central line-associated primary bloodstream infections in a network of Indian hospitals: A prospective surveillance study over 7 years (2017-2024).

Epidemiology of non-central line-associated primary bloodstream infections in a network of Indian hospitals: A prospective surveillance study over 7 years (2017-2024).

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: September 03, 2025

Trends of severe human metapneumovirus infections in India.

Trends of severe human metapneumovirus infections in India.

Journal: BMC infectious diseases

Published: July 26, 2025

Candidaemia and Central Line-Associated Candidaemia in a Network of Indian ICUs: Impact of COVID-19 Pandemic.

Candidaemia and Central Line-Associated Candidaemia in a Network of Indian ICUs: Impact of COVID-19 Pandemic.

Journal: Mycoses

Published: May 15, 2024

Surveillance of ventilator associated pneumonia in a network of indian hospitals using modified definitions: a pilot study.

Surveillance of ventilator associated pneumonia in a network of indian hospitals using modified definitions: a pilot study.

Journal: The Lancet regional health. Southeast Asia

Published: February 14, 2024

Pan-India influenza-like illness (ILI) and Severe acute respiratory infection (SARI) surveillance: epidemiological, clinical and genomic analysis.

Pan-India influenza-like illness (ILI) and Severe acute respiratory infection (SARI) surveillance: epidemiological, clinical and genomic analysis.

Journal: Frontiers in public health

Published: May 06, 2023

India-discovered levonadifloxacin & alalevonadifloxacin: A review on susceptibility testing methods, CLSI quality control and breakpoints along with a brief account of their emerging therapeutic profile as a novel standard-of-care.

India-discovered levonadifloxacin & alalevonadifloxacin: A review on susceptibility testing methods, CLSI quality control and breakpoints along with a brief account of their emerging therapeutic profile as a novel standard-of-care.

Journal: Indian journal of medical microbiology

Published: October 15, 2022

Self-reported survey on infection prevention and control structures in healthcare facilities part of a national level healthcare associated infection surveillance network in India, 2019.

Self-reported survey on infection prevention and control structures in healthcare facilities part of a national level healthcare associated infection surveillance network in India, 2019.

Journal: American journal of infection control

Published: July 12, 2021

Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India.

Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India.

Journal: Viruses

Published: July 09, 2021

In vitro activity of a novel antibacterial agent, levonadifloxacin, against clinical isolates collected in a prospective, multicentre surveillance study in India during 2016-18.

In vitro activity of a novel antibacterial agent, levonadifloxacin, against clinical isolates collected in a prospective, multicentre surveillance study in India during 2016-18.

Journal: The Journal of antimicrobial chemotherapy

Published: July 25, 2019

Showing 1-10 of 10

Last Updated: 09/26/2026